Pharmacokinetics and tolerability of deuterated-tetrabenazine (SD-809) and tetrabenazine in healthy volunteers.

Trial Profile

Pharmacokinetics and tolerability of deuterated-tetrabenazine (SD-809) and tetrabenazine in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Mar 2013

At a glance

  • Drugs Deutetrabenazine (Primary) ; Tetrabenazine
  • Indications Drug-induced dyskinesia; Gilles de la Tourette's syndrome; Huntington's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 23 Mar 2013 Results presented at the 65th Annual Meeting of the American Academy of Neurology.
    • 05 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top